Literature DB >> 9174825

The management of ovarian cancer: an update.

A Onnis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9174825

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN： 0392-2936            Impact factor:   0.196


× No keyword cloud information.
  3 in total

1.  Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen.

Authors:  Douglas J Hanlon; Paulomi B Aldo; Lesley Devine; Ayesha B Alvero; Anna K Engberg; Richard Edelson; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2011-01-18       Impact factor: 3.886

2.  Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.

Authors:  Ayesha B Alvero; Rui Chen; Han-Hsuan Fu; Michele Montagna; Peter E Schwartz; Thomas Rutherford; Dan-Arin Silasi; Karina D Steffensen; Marianne Waldstrom; Irene Visintin; Gil Mor
Journal:  Cell Cycle       Date:  2009-01-01       Impact factor: 4.534

3.  Transimmunization restores immune surveillance and prevents recurrence in a syngeneic mouse model of ovarian cancer.

Authors:  Ayesha B Alvero; Douglas Hanlon; Mary Pitruzzello; Renata Filler; Eve Robinson; Olga Sobolev; Roslyn Tedja; Alessandra Ventura; Marcus Bosenberg; Patrick Han; Richard L Edelson; Gil Mor
Journal:  Oncoimmunology       Date:  2020-05-13       Impact factor: 8.110
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.